MAGNI, PAOLO
MAGNI, PAOLO
Dipartimento di Scienze Farmacologiche e Biomolecolari Rodolfo Paoletti
Multiomics for Risk Stratification in Atherosclerotic Cardiovascular Disease
2026 L.T. Nordestgaard, P. Magni, M. Sopić, M. Chemaly, L. Matic, N. Dalila, F. Trindade, B.N. Wolford, Z. Rodriguez-Hernandez, N. Amigó, A.L. Catapano, L. Masana, Y. Devaux
Beyond weight loss: How metabolism in human adipocytes is shaped by GLP-1R agonists and dual GIPR/GLP-1R agonists
2026 R. Curto, C. Giglione, R. Cannarella, H. Berisha, R. Hattab, R.A. Condorelli, S.L. Vignera, A.E. Calogero, P. Magni
Pharmacological Effects of Angiotensin 1–7 on Venous Vascular Tone
2026 A. Daci, H. Berisha, E. Rexhbeqaj, I. Berisha, K. Zenuni, P. Magni
Relevance of pre-analytical factors in multiomics: Toward a standardized blood processing protocol
2026 F. Trindade, M. Sopić, M.J. Davies, C. Tsatsanis, F. Pinet, H.B. Ferreira, J. Munjas, K.R. Mayilyan, M.M. Formosa, R. Attard, R. Farrugia, R. Vitorino, S. Khatib, S. Bezzina Wettinger, S. Novella, V. Kosek, Y. Sohrabi, P. Magni, Y. Devaux, D. de Gonzalo-Calvo, M. Mardal
Neurofilament Light Chain Levels, Skeletal Muscle Loss, and Nutritional Decline: Key Prognostic Factors in Amyotrophic Lateral Sclerosis
2025 A. Zulueta, R. Piras, D. Azzolino, P. Mariani, R. Sideri, C. Garrè, G. Federico, T. Lucchi, P. Magni, E.A. Parati, C. Lunetta
Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk
2025 H. Berisha, R. Hattab, L. Comi, C. Giglione, S. Migliaccio, P. Magni
Multiomics in atherosclerotic cardiovascular disease
2025 L.T. Nordestgaard, B.N. Wolford, D. de Gonzalo-Calvo, M. Sopić, Y. Devaux, L. Matic, S.B. Wettinger, J.A. Schmid, N. Amigó, L. Masana, A.L. Catapano, D. Kardassis, P. Magni
Editorial: Multiomic approaches in atherosclerosis
2025 M. Sopić, T. Mitić, J. Sluimer, P. Magni, Y. Devaux
Valorizing Agro‐Food Waste for Nutraceutical Development: Sustainable Approaches for Managing Metabolic Dysfunction‐Associated Steatotic Liver Disease and Related Co‐Morbidities
2025 L. Comi, C. Giglione, F.T. Klinaku, F. Pialorsi, V. Tollemeto, M. Zurlo, A. Seneci, P. Magni
Evaluation of Metabolic Dysfunction-Associated Fatty Liver Disease-Related Pathogenic Mechanisms in Human Steatotic Liver Cell-Based Model: Beneficial Effects of Prunus domestica L. subsp. syriaca Extract
2025 L. Comi, C. Giglione, F. Tolaj Klinaku, L. Da Dalt, H. Ullah, M. Daglia, P. Magni
Cytotoxic and dysmetabolic impact of polystyrene nanoplastics, a new potential atherosclerotic cardiovascular risk factor, on a steatosis model of HepG2 cells
2025 C. Giglione, L. Comi, F. Tolaj Klinaku, L. Da Dalt, P. Magni
Toward Precision Medicine in Atherosclerotic Cardiovascular Disease: Insights from Omics Data into Sex Differences
2025 J. Munjas, S. Vladimirov, T. Ratkovic, L. Comi, C. Giglione, I. Tanaskovic, T. Gojkovic, B. Rakic, A. Davidovic, L. Vukmirovic, M. Milanov, D. Cvijanovic, P. Magni, M. Sopic
Impact of spaceflight on endocrine, metabolic and kidney function: current evidence, open issues, and potential countermeasures
2025 P. Magni, G. Ricci, M. Narici, F. Ferranti
Deciphering immune dynamics in atherosclerosis: Inflammatory mediators as biomarkers and therapeutic target
2025 P. Magni, T. Mitić, Y. Devaux, P. Pierre, M. Sopić, F. De La Cuesta, R. Vitorino
Triglycerides as Determinants of Global Lipoprotein Derangement: Implications for Cardiovascular Prevention
2025 N. Amigó, P. Torné, L.T. Nordestgaard, F. Di Giacomo-Barbagallo, C. Merino, P. Magni, A. González-Lleó, N. Andreychuk, A.L. Catapano, L. Masana, D. Ibarretxe
Bottlenecks in advancing and applying multiomic data integration—common data resources as rate-limiting drivers—the high-impact use case of atherosclerotic cardiovascular disease
2025 S. Bezzina Wettinger, K. Karaduzovic-Hadziabdic, R. Attard, R. Farrugia, B.N. Wolford, M. Chierici, G. Jurman, P. Alexiou, J.L. Peñalvo, R.S. Costa, J. Basílio, F. Sabovčik, R. Vitorino, J.A. Schmid, R. Shigdel, B. Vilne, A.G. Hatzigeorgiou, M. Sopic, Y. Devaux, P. Magni, M. Tellez-Plaza, D.P. Kreil, A. Gruca
Efficacy of nutritional plant-based extracts from Aframomum citratum and Xylopia parviflora in mitigating epididymal and excrement fat accumulation in DIO-C57BL/6 mice
2025 A.P.N. Atchan, S.T.S. Murthy, P. Magni, F. Ferriere, G.A. Agbor, J. Kuiate, U.V. Manjappara
Advancing atherosclerosis research: The Power of lipid imaging with MALDI-MSI
2025 C.H.M. Bookmeyer, F.X. Correig, L. Masana, P. Magni, Ó. Yanes, M. Vinaixa
An integrated view of the pathophysiological crosstalk between adipose tissue, bone and cardiovascular system in men and women
2025 F.T. Klinaku, L. Comi, C. Giglione, P. Magni
Role of gliflozins on hepatocellular carcinoma progression: a systematic synthesis of preclinical and clinical evidence
2025 L. Basile, R. Cannarella, P. Magni, R.A. Condorelli, A.E. Calogero, S. La Vignera